NASDAQ, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NASDAQ, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $4.28B | Feb 22, 2019 |
| FY2018 | Dec 31, 2017 | $3.95B | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $3.70B | Feb 22, 2019 |
| FY2017 | Dec 31, 2015 | $3.40B | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $3.50B | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $3.21B | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $3.12B | Feb 17, 2015 |
| FY2013 | Dec 31, 2011 | $3.44B | Feb 24, 2014 |
| FY2012 | Dec 31, 2010 | $3.19B | Feb 21, 2013 |
| FY2011 | Dec 31, 2009 | $3.41B | Feb 24, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.26B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $7.40B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $6.06B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $6.23B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $5.89B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $5.63B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.26B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $4.28B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $3.95B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $3.70B | Feb 22, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.25B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.65B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $3.90B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $3.58B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $3.42B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $2.90B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.54B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $2.53B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $2.41B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $2.28B | Feb 22, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.79B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.06B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.13B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.19B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $933.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $774.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $458.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $729.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $106.00M | Feb 22, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.80B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.58B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.56B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.44B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.23B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.02B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.03B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $991.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $836.00M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.94B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.70B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.71B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.08B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.25B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $963.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.03B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $909.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $776.00M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $266.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $207.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $158.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $152.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $163.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $188.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $127.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $111.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $144.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $134.00M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.05B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $30.40B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $32.29B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $20.87B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $20.12B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $17.98B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $13.92B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $15.70B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $15.35B | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $13.41B | Feb 22, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.82B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $19.20B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $21.47B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $14.70B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $13.71B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $11.54B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $8.29B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $10.25B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $9.47B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $8.72B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.23B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $11.19B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $10.82B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $6.15B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $6.40B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $6.43B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $5.64B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $5.45B | Feb 25, 2020 |
| FY2019 | Dec 31, 2017 | $5.88B | Feb 25, 2020 |
| FY2017 | Dec 31, 2016 | $5.43B | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.37B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $13.96B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $14.11B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $8.10B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $8.43B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $6.85B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $6.37B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $6.36B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $6.59B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $6.03B | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.59B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $8.40B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $7.83B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $7.21B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $6.47B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $5.63B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $5.03B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.56B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $3.96B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $3.48B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $604.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $592.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $453.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $502.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $393.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $2.75B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $332.00M | Feb 23, 2022 |
| FY2019 | Dec 31, 2018 | $545.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $377.00M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $403.00M | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.57B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $8.58B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $9.67B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $4.74B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $4.31B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $4.94B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $3.00B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.36B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $3.13B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $3.60B | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 4 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 22, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 4 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 22, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 569.89M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 575.06M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 575.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 492.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 500.00M | Feb 21, 2024 |
| FY2021 | Dec 31, 2020 | 164.93M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 165.09M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | 165.17M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 167.44M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 166.58M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $383.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $350.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2020 | $320.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2019 | $305.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2018 | $280.00M | Feb 22, 2019 |